# Safety Study of Oral BTA9881 to Treat RSV Infection

> **NCT00504907** · PHASE1 · COMPLETED · sponsor: **Biota Scientific Management Pty Ltd** · enrollment: 63 (actual)

## Conditions studied

- Respiratory Syncytial Virus Infections

## Interventions

- **DRUG:** BTA9881
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00504907
- **Lead sponsor:** Biota Scientific Management Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2018-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00504907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00504907, "Safety Study of Oral BTA9881 to Treat RSV Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00504907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*